- Home
- ARCT vs BKT Comparison
ARCT vs BKT Comparison
Compare ARCT & BKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- BKT
- Stock Information
- Founded
- ARCT 2013
- BKT 1988
- Country
- ARCT United States
- BKT United States
- Employees
- ARCT N/A
- BKT N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- BKT Investment Bankers/Brokers/Service
- Sector
- ARCT Health Care
- BKT Finance
- Exchange
- ARCT Nasdaq
- BKT Nasdaq
- Market Cap
- ARCT 298.3M
- BKT 245.7M
- IPO Year
- ARCT N/A
- BKT N/A
- Fundamental
- Price
- ARCT $13.95
- BKT $11.61
- Analyst Decision
- ARCT Strong Buy
- BKT
- Analyst Count
- ARCT 8
- BKT 0
- Target Price
- ARCT $52.33
- BKT N/A
- AVG Volume (30 Days)
- ARCT 473.8K
- BKT 67.9K
- Earning Date
- ARCT 08-04-2025
- BKT 01-01-0001
- Dividend Yield
- ARCT N/A
- BKT 8.97%
- EPS Growth
- ARCT N/A
- BKT N/A
- EPS
- ARCT N/A
- BKT N/A
- Revenue
- ARCT $143,680,000.00
- BKT N/A
- Revenue This Year
- ARCT N/A
- BKT N/A
- Revenue Next Year
- ARCT $34.79
- BKT N/A
- P/E Ratio
- ARCT N/A
- BKT N/A
- Revenue Growth
- ARCT 15.38
- BKT N/A
- 52 Week Low
- ARCT $8.04
- BKT $10.55
- 52 Week High
- ARCT $27.54
- BKT $12.92
- Technical
- Relative Strength Index (RSI)
- ARCT 62.93
- BKT 54.96
- Support Level
- ARCT $12.03
- BKT $11.31
- Resistance Level
- ARCT $13.42
- BKT $11.67
- Average True Range (ATR)
- ARCT 0.81
- BKT 0.08
- MACD
- ARCT 0.09
- BKT 0.01
- Stochastic Oscillator
- ARCT 97.25
- BKT 75.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About BKT BlackRock Income Trust Inc. (The)
Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65 percent of its assets in mortgage-backed securities. The Fund invests at least 80 percent of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings (S&P) or Aaa by Moody's Investors Service, Inc (Moody's). The Fund may invest directly in such securities or synthetically through the use of derivatives.